A phase I study of gemcitabine, capecitabine, and vandetanib in patients with advanced solid tumors with an expanded cohort in biliary and pancreatic malignancies

被引：0
|
作者：
Nallapareddy, S.
Eckhardt, S. G.
O'Bryant, C. L.
Eppers, S.
Diab, S.
Kane, M. A.
Weekes, C. D.
Spratlin, J. L.
Messersmith, W. A.
Leong, S.
机构：
[1] Univ Colorado, Ctr Canc, Aurora, CO USA
[2] Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.2535
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2535
引用
下载
收藏
页数：1
相关论文
共 50 条
  • [21] A Phase I study of pazopanib in combination with gemcitabine in patients with advanced solid tumors
    Plummer, Ruth
    Madi, Ayman
    Jeffels, Melinda
    Richly, Heike
    Nokay, Bahar
    Rubin, Stephen
    Ball, Howard A.
    Weller, Steve
    Botbyl, Jeffrey
    Gibson, Diana M.
    Scheulen, Max E.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (01) : 93 - 101
  • [22] A Phase I study of pazopanib in combination with gemcitabine in patients with advanced solid tumors
    Ruth Plummer
    Ayman Madi
    Melinda Jeffels
    Heike Richly
    Bahar Nokay
    Stephen Rubin
    Howard A. Ball
    Steve Weller
    Jeffrey Botbyl
    Diana M. Gibson
    Max E. Scheulen
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 93 - 101
  • [23] Safety and activity of vandetanib in combination with everolimus in patients with advanced solid tumors: a phase I study
    Cascone, T.
    Sacks, R. L.
    Subbiah, I. M.
    Drobnitzky, N.
    Piha-Paul, S. A.
    Hong, D. S.
    Hess, K. R.
    Amini, B.
    Bhatt, T.
    Fu, S.
    Naing, A.
    Janku, F.
    Karp, D.
    Falchook, G. S.
    Conley, A. P.
    Sherman, S., I
    Meric-Bernstam, F.
    Ryan, A. J.
    Heymach, J., V
    Subbiah, V
    ESMO OPEN, 2021, 6 (02)
  • [24] A phase I study of topotecan and gemcitabine in advanced solid tumors
    Derek S. Serna
    Tanios Bekaii-Saab
    Eric H. Kraut
    Investigational New Drugs, 2011, 29 : 1390 - 1394
  • [25] A phase I trial of romidepsin in combination with gemcitabine in patients with pancreatic and other advanced solid tumors
    Doss, H. H.
    Jones, S. F.
    Infante, J. R.
    Spigel, D. R.
    Willcutt, N.
    Lamar, R.
    Barton, J.
    Keegan, M.
    Burris, H. A., III
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [26] A phase I study of topotecan and gemcitabine in advanced solid tumors
    Serna, Derek S.
    Bekaii-Saab, Tanios
    Kraut, Eric H.
    INVESTIGATIONAL NEW DRUGS, 2011, 29 (06) : 1390 - 1394
  • [27] Gemcitabine and vinorelbine, a phase I study in patients with advanced malignancies
    Chaouche, M
    Delord, JP
    Raymond, E
    Vayre, L
    Ducreux, M
    Ruffle, P
    Rodier, JM
    Armand, JP
    ANNALS OF ONCOLOGY, 1998, 9 : 165 - 165
  • [28] Phase I study of rubitecan and gemcitabine in patients with advanced malignancies
    Fracasso, PM
    Rader, JS
    Govindan, R
    Herzog, TJ
    Arquette, MA
    Denes, A
    Mutch, DG
    Picus, J
    Tan, BR
    Fears, CL
    Goodner, SA
    Sun, SL
    ANNALS OF ONCOLOGY, 2002, 13 (11) : 1819 - 1825
  • [29] Combining capecitabine and gemcitabine in patients with advanced pancreatic carcinoma: A phase I/II trial
    Hess, V
    Salzberg, M
    Borner, M
    Morant, R
    Roth, AD
    Ludwig, C
    Herrmann, R
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (01) : 66 - 68
  • [30] Phase I combination study of trabectedin and capecitabine in patients with advanced malignancies
    Gore, Lia
    Rivera, E.
    Basche, M.
    Moulder-Thompson, S. L.
    Li, J.
    Eppers, S.
    Grolnic, S.
    O'Bryant, C.
    Cleere, D.
    Elsayed, Y. A.
    Eckhardt, S. G.
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (05) : 1942 - 1949
12345